Are You Paying Too Much for Pregabalin?
Restricting trial enrollment to patients with moderate to severe symptoms could improve precision in effectiveness estimates and reduce uncertainty in economic evaluations. Development of FM-specific utility measures that capture the condition’s multidimensional impact would enable a more accurate valuation of treatment benefits. Clinical evidence examining treatment sequences and long-term outcomes could inform more realistic model …
